Subsequent investigators described that serum NfH levels were higher in diabetic neuropathy than in diabetics without neuropathy [14], and plasma levels were higher in critical illness neuropathy/myopathy (CINM) compared to other intensive care patients [15]; once again, in these studies, there was significant overlap in NfH levels between groups. Here, NEFH is linked to diabetic neuropathy.